Bio Green Med Solution (BGMS) Earnings Analysis
Bio Green Med Solution (BGMS) next reports earnings on 2026-08-12. It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -0.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BGMS next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
BGMS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.03975 USD | n/a | n/a | n/a |
| 2026-03-30 | -2.21 USD | -72 USD | +96.9% | Beat |
| 2025-11-13 | -1.31 USD | -72 USD | +98.2% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
BGMS valuation and analyst view
| Trailing P/E | -0.20 |
|---|---|
| Trailing EPS | -0.57048 USD |
| Price / book | 0.72 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bio Green Med Solution (BGMS)'s next earnings date?
Bio Green Med Solution is next scheduled to report on 2026-08-12.
Did BGMS beat earnings last quarter?
Consensus estimate data was not available for BGMS's 2026-05-14 report.
What is BGMS's earnings track record?
Over the last 2 reported quarters with consensus data, BGMS beat estimates 2 times (100%).
What is BGMS's current P/E ratio and EPS?
BGMS trades at a trailing P/E of -0.20 on trailing EPS of -0.5704797085826968 USD.
What do analysts rate BGMS?
BGMS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.